Lisa Ooi

Lisa is the Vice President of Strategy at Hummingbird Bioscience. Lisa has more than 18 years of experience in the biomedical industry in the areas of oncology/hematology, oncology biomarker development, clinical pharmacology, preclinical and clinical development, as well as large-scale private and public research partnerships and investment promotion. She has previous experience at the Singapore Economic Development Board, ASLAN Pharmaceuticals, Bayer Healthcare, the Agency for Science Technology and Research (A*STAR), and served on the boards of multiple biomedical entities such as Precision Health Research, Singapore (PRECISE) and the Singapore Clinical Research Institute (SCRI). Lisa holds a BSc in Biochemistry from the University of Wisconsin-Madison, a MSc and PhD from Stanford University in Chemical Engineering and Chemical and Systems Biology.